Catalyst Funds Management Pty LTD Eledon Pharmaceuticals, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $662 Billion
- Q3 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 11,400 shares of ELDN stock, worth $20,064. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,400
Previous 13,620
16.3%
Holding current value
$20,064
Previous $46.2 Million
36.05%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ELDN
# of Institutions
88Shares Held
32.2MCall Options Held
0Put Options Held
360K-
Bvf Inc San Francisco, CA6.29MShares$11.1 Million0.88% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$6.28 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$5.75 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.07MShares$3.65 Million0.21% of portfolio
-
Zimmer Partners, LP New York, NY1.83MShares$3.21 Million0.13% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $24.2M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...